Daily Cosmetic Research Analysis
A double-blind randomized split-face trial found letibotulinumtoxinA achieved comparable wrinkle reduction with more limited diffusion versus onabotulinumtoxinA/abobotulinumtoxinA, informing safer aesthetic neuromodulator use. A randomized controlled trial showed 1% povidone-iodine mouthwash with scaling and root planing improved short-term periodontal outcomes with acceptability comparable to chlorhexidine. An in vivo volunteer study linked fragrance evaporation variability to both skin physico
Summary
A double-blind randomized split-face trial found letibotulinumtoxinA achieved comparable wrinkle reduction with more limited diffusion versus onabotulinumtoxinA/abobotulinumtoxinA, informing safer aesthetic neuromodulator use. A randomized controlled trial showed 1% povidone-iodine mouthwash with scaling and root planing improved short-term periodontal outcomes with acceptability comparable to chlorhexidine. An in vivo volunteer study linked fragrance evaporation variability to both skin physicochemical properties and intrinsic fragrance molecular traits.
Research Themes
- Optimizing botulinum toxin formulations for precise aesthetic outcomes
- Adjunctive oral-care strategies with cosmetic relevance in periodontal treatment
- Personalization of fragrance performance based on skin–molecule interactions
Selected Articles
1. Diffusion Characteristics of LetibotulinumtoxinA, OnabotulinumtoxinA, and AbobotulinumtoxinA and its Impact on Muscle Relaxation: A Randomized Split-Face Clinical Trial.
This double-blind randomized split-face trial (n=30) found letibotulinumtoxinA produced comparable wrinkle reduction with a significantly smaller maximal anhidrotic area versus onabotulinumtoxinA, indicating more limited diffusion. Standardized photography and the Minor starch-iodine test over 6 months supported its precise action.
Impact: Direct head-to-head, registered RCT evidence about diffusion characteristics can refine product selection and dosing in aesthetic practice where precision is critical.
Clinical Implications: When minimizing toxin spread is important (e.g., small treatment zones, ptosis risk), letibotulinumtoxinA may be preferred due to its limited diffusion while maintaining efficacy.
Key Findings
- LetibotulinumtoxinA showed a significantly smaller maximal anhidrotic area than onabotulinumtoxinA on the contralateral side.
- Wrinkle reduction was achieved across arms as assessed by standardized photography and the Croma Scale.
- Diffusion behavior was quantified longitudinally over 6 months using Minor's starch-iodine test in a split-face design.
Methodological Strengths
- Double-blind randomized split-face design controls for inter-individual variability
- Objective diffusion assessment via Minor's starch-iodine test plus standardized photographic scoring
- Prospective 6-month follow-up and trial registration (EU CT: 2024-511047-26-01)
Limitations
- Modest sample size (n=30) limits precision and subgroup analyses
- Single facial muscle (frontalis) and split-face comparison may not generalize to other regions or dosing paradigms
- Incomplete reporting of some numerical outcomes in the abstract
Future Directions: Larger multicenter RCTs across multiple facial muscles with standardized dose equivalence are needed to confirm diffusion profiles, safety, and patient-reported outcomes.
INTRODUCTION: Injections with botulinumtoxinA (BoNTA) are the most common nonsurgical aesthetic procedure but carry risks such as unintended muscle diffusion. Understanding formulation behavior is key to optimizing safety and efficacy. This study compares the diffusion characteristics from letibotulinumtoxinA (Leti-BoNTA) to onabotulinumtoxinA (Ona-BoNTA) and abobotulinumtoxinA (Abo-BoNTA) and its impact on muscle relaxation of frontalis muscle. METHODS: In a double-blind, randomized trial, 30 healthy adults received Leti-BoNTA on one forehead side and either Ona-BoNTA or Abo-BoNTA on the other. Anhidrosis was measured via Minor's starch test over 6 months, and wrinkle severity was assessed using standardized photography and the Croma Scale. RESULTS: Leti-BoNTA had a significantly smaller maximal anhidrotic area than Ona-BoNTA (-15.1 ± 5.5 cm CONCLUSIONS: Leti-BoNTA provides wrinkle reduction with a more limited diffusion, as assessed with the Minor's starch-iodine test. Its precise action in this trial implies to be a viable option when controlled spread is essential. CLINICAL TRIAL REGISTRATION: The trial EU CT: 2024-511047-26-01 was registered on 23 March 2024.
2. [Efficacy of 1% povidone-iodine mouthwash combined with scaling and root planing in the treatment of periodontitis: a randomized, controlled trial].
In a three-arm randomized trial (n=75; 63 completed), 1% povidone-iodine mouthwash used for one week after scaling and root planing yielded significant short-term improvements in clinical, microbial, and inflammatory metrics, not inferior to chlorhexidine. Patient acceptability favored povidone-iodine.
Impact: Identifies a widely accessible alternative to chlorhexidine with favorable acceptability, informing adjunctive oral-care choices that have cosmetic relevance (plaque/stain) and periodontal benefits.
Clinical Implications: Clinicians can consider 1% povidone-iodine mouthwash as a short-term adjunct after SRP for stage I/II periodontitis, especially when chlorhexidine tolerability is a concern.
Key Findings
- Randomized three-arm design compared 1% povidone-iodine, chlorhexidine, and saline placebo after SRP.
- Significant short-term improvements in clinical, microbial, and inflammatory parameters across groups; povidone-iodine not inferior to chlorhexidine.
- Patient-reported acceptability was better for povidone-iodine than chlorhexidine.
Methodological Strengths
- Randomized controlled, three-arm comparative design
- Multidimensional outcomes (clinical, microbiological, inflammatory, patient-reported) with assessments at 1, 4, and 12 weeks
Limitations
- Short-term follow-up and modest sample size limit long-term inference
- Blinding and allocation concealment procedures are not described
- Single-center setting may limit generalizability
Future Directions: Larger multicenter, blinded RCTs with longer follow-up should compare efficacy, adverse effects (e.g., staining, taste), and microbiome impacts between povidone-iodine and chlorhexidine.
OBJECTIVES: This study aimed to evaluate the therapeutic effect of 1% povidone-iodine mouthwash combined with scaling and root planing in patients with stage Ⅰ/Ⅱ class A/B periodontitis, and to provide a basis for the clinical application of povidone-iodine mouthwash. METHODS: Seventy-five subjects were included in this trial and randomly divided into three groups. After full-mouth ultrasonic supragingival cleansing, scaling and root planing, the placebo group was treated with sodium chloride injection (NaCl group), the control group was treated with compound chlorhexidine mouthwash (CHX group), and the experimental group was treated with 1% povidone-iodine mouthwash (PVP-I group), and rinsed their mouths for 1 week, respectively. Subjects were tested at 1, 4, and 12 weeks after dosing for clinical indicators, microbial composition of supragingival plaque, gingival crevicular fluid inflammatory marker levels, and patient-reported outcomes. RESULTS: Sixty-three subjects completed the follow-up. After treatment, the clinical indicators, microbial indicators, and inflammatory indicators were all significantly improved ( CONCLUSIONS: 1% PVP-I mouthwash combined with scaling and root planing can effectively reduce gingival inflammation and dental plaque, improve clinical symptoms in the short term. While its efficacy is not significantly inferior to that of chlorhexidine, PVP-I mouthwash is more acceptable to patients than chlorhexidine.
3. Exploring the impact of fragrance molecular and skin properties on the evaporation profile of fragrances.
In vivo measurements on volunteers semi-quantified fragrance evaporation from skin and linked inter-individual variability to both skin physicochemical properties and intrinsic fragrance molecular traits. Statistical analyses highlighted that evaporation profiles are co-determined by the substrate (skin type) and molecule characteristics.
Impact: Provides human in vivo evidence to personalize fragrance formulation and application strategies by accounting for skin-specific properties, a key factor in consumer-perceived performance.
Clinical Implications: While not a clinical intervention, the findings inform cosmetic product development and counseling (e.g., tailoring fragrance choice or vehicle to skin type to optimize performance).
Key Findings
- Fragrance evaporation rates varied markedly across individuals when measured directly on skin.
- Measured skin properties helped explain differences in evaporation profiles between volunteers.
- Statistical analysis indicated that both intrinsic fragrance molecular features and skin physicochemical characteristics co-determine evaporation behavior.
Methodological Strengths
- In vivo human skin assessment increases ecological validity for cosmetic use
- Integrated measurement of both substrate (skin) properties and fragrance molecular characteristics with statistical modeling
Limitations
- Sample size and participant characteristics are not specified in the abstract
- Semi-quantitative evaporation approach may limit precision and comparability
- Short-term measurements without controlled environmental replication across sessions
Future Directions: Larger, controlled studies with standardized environmental conditions and quantitative mass spectrometry could refine models to predict evaporation based on skin profiling and molecular descriptors.
An evaporation study was conducted on the skin of several volunteers to examine whether skin properties influence fragrance molecules' evaporation rates. The aim was to identify the observed variations and explore the responsible fragrance molecular and skin factors. To study the evaporation phenomenon, fragrance molecules evaporation was semi-quantified from each volunteer's skin. This approach allowed a comparison of evaporation across individuals and provided insights into how the fragrance molecules interacted differently depending on skin types. Skin properties were subsequently measured to explain the observed differences in evaporation between individuals. Statistical analysis was performed to understand how both skin type and the intrinsic properties of fragrance molecules contribute to the observed variations in evaporation rates. This study offers promising results, advancing our understanding of the evaporation behaviour of fragrance molecules and its relationship with the physicochemical properties of the skin and the intrinsic characteristics of the fragrances. Une étude d'évaporation a été menée sur la peau de plusieurs volontaires pour examiner si les propriétés cutanées influencent les taux d'évaporation des molécules de parfum. L'objectif était d'identifier les variations observées ainsi que les facteurs moléculaires des parfums et les facteurs cutanés responsables. Pour étudier le phénomène d'évaporation, l'évaporation des molécules de parfum a été semi‐quantifiée à partir de la peau de chaque volontaire. Cette approche a permis de comparer l'évaporation entre les individus et a fourni des informations sur les différences d'interaction des molécules de parfum selon les types de peau. Les propriétés cutanées ont ensuite été mesurées pour expliquer les différences d'évaporation observées entre les individus. Une analyse statistique a été réalisée pour comprendre la façon dont le type de peau ainsi que les propriétés intrinsèques des molécules de parfum contribuent aux variations des taux d'évaporation observées. Cette étude offre des résultats prometteurs et fait progresser notre compréhension du comportement d'évaporation des molécules de parfum, ainsi que leur relation avec les propriétés physico‐chimiques de la peau et les caractéristiques intrinsèques des parfums.